Search results

We want you to be involved in our work - whether you’re commenting on our draft recommendations, taking part in guidance development or attending a committee meeting, your voice is important to us.

Clarification on demonstrating patient access to medicines and treatments recommended by NICE Technology Appraisal (TA) or Highly Specialised Technologies (HST) guidance.

NICE has a key role in UK licensing and the evaluation of and access to new and innovative products for the health system.

Before 2022, we used different processes for assessing technologies. You can view the previous process and methods guides below.

How providers and commissioners can use quality standards to improve the quality of care

We assess the efficacy and safety of interventional procedures used for treatment or diagnosis to determine whether they work well enough and are safe enough for use in the NHS.

The Office for Digital Health strives to accelerate NICE's efforts to deliver innovation to the health and care system.

A joint NICE and NHS England meeting can help to ensure you're ready for NHS patient access and subsequent NICE appraisal

We use 3 processes for assessing technologies: the single technology appraisal, the multiple technology appraisal and the cost comparison appraisal

Home What NICE does Our research work HTA Lab...

Past technology appraisal appeals and decisions

NICE standards for innovators of digital health technologies and NHS commissioners

Get expert advice and support from NICE International, part of the UK's National Institute for Health and Care Excellence, for a project in your country

Our indicators measure outcomes that reflect the quality of care or processes linked by evidence to improved outcomes.

Our quality standards set out priority areas for quality improvement in health, public health and social care.